179 related articles for article (PubMed ID: 21357677)
21. Transcription factor-7-like 2 (
Nguyen-Tu MS; da Silva Xavier G; Leclerc I; Rutter GA
J Biol Chem; 2018 Sep; 293(36):14178-14189. PubMed ID: 29967064
[TBL] [Abstract][Full Text] [Related]
22. Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets.
Weise A; Bruser K; Elfert S; Wallmen B; Wittel Y; Wöhrle S; Hecht A
Nucleic Acids Res; 2010 Apr; 38(6):1964-81. PubMed ID: 20044351
[TBL] [Abstract][Full Text] [Related]
23. Requirement of TCF7L2 for TGF-beta-dependent transcriptional activation of the TMEPAI gene.
Nakano N; Itoh S; Watanabe Y; Maeyama K; Itoh F; Kato M
J Biol Chem; 2010 Dec; 285(49):38023-33. PubMed ID: 20889500
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic Pericytes Support β-Cell Function in a Tcf7l2-Dependent Manner.
Sakhneny L; Rachi E; Epshtein A; Guez HC; Wald-Altman S; Lisnyansky M; Khalifa-Malka L; Hazan A; Baer D; Priel A; Weil M; Landsman L
Diabetes; 2018 Mar; 67(3):437-447. PubMed ID: 29246974
[TBL] [Abstract][Full Text] [Related]
25. MiR-205 is up-regulated in islets of diabetes-susceptible mice and targets the diabetes gene Tcf7l2.
Ouni M; Gottmann P; Westholm E; Schwerbel K; Jähnert M; Stadion M; Rittig K; Vogel H; Schürmann A
Acta Physiol (Oxf); 2021 Aug; 232(4):e13693. PubMed ID: 34028994
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
Wang X; Sterr M; Burtscher I; Chen S; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Cernilogar FM; Schotta G; Irmler M; Beckers J; Hrabě de Angelis M; Ray M; Wright CVE; Bakhti M; Lickert H
Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371
[TBL] [Abstract][Full Text] [Related]
27. The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis.
Ip W; Shao W; Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2012 Nov; 303(9):E1166-76. PubMed ID: 22967502
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice.
da Silva Xavier G; Mondragon A; Mourougavelou V; Cruciani-Guglielmacci C; Denom J; Herrera PL; Magnan C; Rutter GA
Diabetologia; 2017 Jun; 60(6):1043-1050. PubMed ID: 28343277
[TBL] [Abstract][Full Text] [Related]
29. Developmentally regulated
Young RM; Ewan KB; Ferrer VP; Allende ML; Godovac-Zimmermann J; Dale TC; Wilson SW
Elife; 2019 Dec; 8():. PubMed ID: 31829936
[TBL] [Abstract][Full Text] [Related]
30. Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.
Hou N; Ye B; Li X; Margulies KB; Xu H; Wang X; Li F
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301468
[TBL] [Abstract][Full Text] [Related]
31. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
Jin T; Liu L
Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
[TBL] [Abstract][Full Text] [Related]
32. The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function.
Chen X; Ayala I; Shannon C; Fourcaudot M; Acharya NK; Jenkinson CP; Heikkinen S; Norton L
Diabetes; 2018 Apr; 67(4):554-568. PubMed ID: 29317436
[TBL] [Abstract][Full Text] [Related]
33. Role of Wnt signaling pathways in type 2 diabetes mellitus.
Chen J; Ning C; Mu J; Li D; Ma Y; Meng X
Mol Cell Biochem; 2021 May; 476(5):2219-2232. PubMed ID: 33566231
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific alternative splicing of TCF7L2.
Prokunina-Olsson L; Welch C; Hansson O; Adhikari N; Scott LJ; Usher N; Tong M; Sprau A; Swift A; Bonnycastle LL; Erdos MR; He Z; Saxena R; Harmon B; Kotova O; Hoffman EP; Altshuler D; Groop L; Boehnke M; Collins FS; Hall JL
Hum Mol Genet; 2009 Oct; 18(20):3795-804. PubMed ID: 19602480
[TBL] [Abstract][Full Text] [Related]
35. Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.
Hansson O; Zhou Y; Renström E; Osmark P
Curr Diab Rep; 2010 Dec; 10(6):444-51. PubMed ID: 20878273
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
37. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
38. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta.
Yi F; Brubaker PL; Jin T
J Biol Chem; 2005 Jan; 280(2):1457-64. PubMed ID: 15525634
[TBL] [Abstract][Full Text] [Related]
39. TCF7L2 promotes beta cell regeneration in human and mouse pancreas.
Shu L; Zien K; Gutjahr G; Oberholzer J; Pattou F; Kerr-Conte J; Maedler K
Diabetologia; 2012 Dec; 55(12):3296-307. PubMed ID: 22945304
[TBL] [Abstract][Full Text] [Related]
40. A context-specific cardiac β-catenin and GATA4 interaction influences TCF7L2 occupancy and remodels chromatin driving disease progression in the adult heart.
Iyer LM; Nagarajan S; Woelfer M; Schoger E; Khadjeh S; Zafiriou MP; Kari V; Herting J; Pang ST; Weber T; Rathjens FS; Fischer TH; Toischer K; Hasenfuss G; Noack C; Johnsen SA; Zelarayán LC
Nucleic Acids Res; 2018 Apr; 46(6):2850-2867. PubMed ID: 29394407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
